Home Biotechnology Biologics Market Size, Top Share, Global Trends And Forecast to 2033

Biologics Market Size & Outlook, 2025-2033

Biologics Market Size, Share & Trends Analysis Report By Source (Microbial, Mammalian, Others), By Manufacturing (In-house, Outsourced ), By Product (Monoclonal Antibodies , Vaccines, Recombinant Proteins, Antisense & RNAi Therapeutics, Others), By Disease Category (Oncology, Infectious Diseases, Immunological Disorders, Cardiovascular Disorders, Hematological Disorders, Others), By Type (Tumor Necrosis Factor (TNF) Inhibitor, T-cell Inhibitor, Selective Co-stimulation Modulators, Interleukin-6 (IL-6) or Interleukin-17 Blocker, Interleukin-1 (IL-1) Blocker, B-cell Inhibitor), By Drug Class (Monoclonal Antibody, Recombinant Insulin, Vaccine, Blood Factor, Human Growth Hormone, Erythropoietin, Fusion Protein, Recombinant Enzyme, Interferon, Colony-stimulating Factor, Gene Therapy, Cell Therapy, Oligonucleotides, Peptide, Botulinum Toxin, Others), By Drug Type (Branded Drugs, Generic Drugs), By Mode of Purchase (Prescription Drugs, Over-the-counter (OTC) Drugs), By Dosage Form (Injection, Tablets, Others), By Route of Administration (Parenteral, Oral, Others), By End-Users (Hospitals, Specialty Clinics, Homecare, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRBI1672DR
Last Updated : Apr, 2025
Pages : 110
Author : Dhanashri Bhapakar
Format : PDF, Excel

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Biologics Market Introduction
    2. By Source
      1. Introduction
        1. Source By Value
      2. Microbial
        1. By Value
      3. Mammalian
        1. By Value
      4. Others
        1. By Value
    3. By Manufacturing
      1. Introduction
        1. Manufacturing By Value
      2. In-house
        1. By Value
      3. Outsourced 
        1. By Value
    4. By Product
      1. Introduction
        1. Product By Value
      2. Monoclonal Antibodies 
        1. By Value
      3. Vaccines
        1. By Value
      4. Recombinant Proteins
        1. By Value
      5. Antisense & RNAi Therapeutics
        1. By Value
      6. Others
        1. By Value
    5. By Disease Category
      1. Introduction
        1. Disease Category By Value
      2. Oncology
        1. By Value
      3. Infectious Diseases
        1. By Value
      4. Immunological Disorders
        1. By Value
      5. Cardiovascular Disorders
        1. By Value
      6. Hematological Disorders
        1. By Value
      7. Others
        1. By Value
    6. By Type
      1. Introduction
        1. Type By Value
      2. Tumor Necrosis Factor (TNF) Inhibitor
        1. By Value
      3. T-cell Inhibitor
        1. By Value
      4. Selective Co-stimulation Modulators
        1. By Value
      5. Interleukin-6 (IL-6) or Interleukin-17 Blocker
        1. By Value
      6. Interleukin-1 (IL-1) Blocker
        1. By Value
      7. B-cell Inhibitor
        1. By Value
    7. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Monoclonal Antibody
        1. By Value
      3. Recombinant Insulin
        1. By Value
      4. Vaccine
        1. By Value
      5. Blood Factor
        1. By Value
      6. Human Growth Hormone
        1. By Value
      7. Erythropoietin
        1. By Value
      8. Fusion Protein
        1. By Value
      9. Recombinant Enzyme
        1. By Value
      10. Interferon
        1. By Value
      11. Colony-stimulating Factor
        1. By Value
      12. Gene Therapy
        1. By Value
      13. Cell Therapy
        1. By Value
      14. Oligonucleotides
        1. By Value
      15. Peptide
        1. By Value
      16. Botulinum Toxin
        1. By Value
      17. Others
        1. By Value
    8. By Drug Type
      1. Introduction
        1. Drug Type By Value
      2. Branded Drugs
        1. By Value
      3. Generic Drugs
        1. By Value
    9. By Mode of Purchase
      1. Introduction
        1. Mode of Purchase By Value
      2. Prescription Drugs
        1. By Value
      3. Over-the-counter (OTC) Drugs
        1. By Value
    10. By Dosage Form
      1. Introduction
        1. Dosage Form By Value
      2. Injection
        1. By Value
      3. Tablets
        1. By Value
      4. Others
        1. By Value
    11. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Parenteral
        1. By Value
      3. Oral
        1. By Value
      4. Others
        1. By Value
    12. By End-Users
      1. Introduction
        1. End-Users By Value
      2. Hospitals
        1. By Value
      3. Specialty Clinics
        1. By Value
      4. Homecare
        1. By Value
      5. Others
        1. By Value
    13. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Hospital Pharmacy
        1. By Value
      3. Retail Pharmacy
        1. By Value
      4. Online Pharmacy
        1. By Value
      5. Others
        1. By Value
    1. Introduction
    2. By Source
      1. Introduction
        1. Source By Value
      2. Microbial
        1. By Value
      3. Mammalian
        1. By Value
      4. Others
        1. By Value
    3. By Manufacturing
      1. Introduction
        1. Manufacturing By Value
      2. In-house
        1. By Value
      3. Outsourced 
        1. By Value
    4. By Product
      1. Introduction
        1. Product By Value
      2. Monoclonal Antibodies 
        1. By Value
      3. Vaccines
        1. By Value
      4. Recombinant Proteins
        1. By Value
      5. Antisense & RNAi Therapeutics
        1. By Value
      6. Others
        1. By Value
    5. By Disease Category
      1. Introduction
        1. Disease Category By Value
      2. Oncology
        1. By Value
      3. Infectious Diseases
        1. By Value
      4. Immunological Disorders
        1. By Value
      5. Cardiovascular Disorders
        1. By Value
      6. Hematological Disorders
        1. By Value
      7. Others
        1. By Value
    6. By Type
      1. Introduction
        1. Type By Value
      2. Tumor Necrosis Factor (TNF) Inhibitor
        1. By Value
      3. T-cell Inhibitor
        1. By Value
      4. Selective Co-stimulation Modulators
        1. By Value
      5. Interleukin-6 (IL-6) or Interleukin-17 Blocker
        1. By Value
      6. Interleukin-1 (IL-1) Blocker
        1. By Value
      7. B-cell Inhibitor
        1. By Value
    7. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Monoclonal Antibody
        1. By Value
      3. Recombinant Insulin
        1. By Value
      4. Vaccine
        1. By Value
      5. Blood Factor
        1. By Value
      6. Human Growth Hormone
        1. By Value
      7. Erythropoietin
        1. By Value
      8. Fusion Protein
        1. By Value
      9. Recombinant Enzyme
        1. By Value
      10. Interferon
        1. By Value
      11. Colony-stimulating Factor
        1. By Value
      12. Gene Therapy
        1. By Value
      13. Cell Therapy
        1. By Value
      14. Oligonucleotides
        1. By Value
      15. Peptide
        1. By Value
      16. Botulinum Toxin
        1. By Value
      17. Others
        1. By Value
    8. By Drug Type
      1. Introduction
        1. Drug Type By Value
      2. Branded Drugs
        1. By Value
      3. Generic Drugs
        1. By Value
    9. By Mode of Purchase
      1. Introduction
        1. Mode of Purchase By Value
      2. Prescription Drugs
        1. By Value
      3. Over-the-counter (OTC) Drugs
        1. By Value
    10. By Dosage Form
      1. Introduction
        1. Dosage Form By Value
      2. Injection
        1. By Value
      3. Tablets
        1. By Value
      4. Others
        1. By Value
    11. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Parenteral
        1. By Value
      3. Oral
        1. By Value
      4. Others
        1. By Value
    12. By End-Users
      1. Introduction
        1. End-Users By Value
      2. Hospitals
        1. By Value
      3. Specialty Clinics
        1. By Value
      4. Homecare
        1. By Value
      5. Others
        1. By Value
    13. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Hospital Pharmacy
        1. By Value
      3. Retail Pharmacy
        1. By Value
      4. Online Pharmacy
        1. By Value
      5. Others
        1. By Value
    14. U.S.
      1. By Source
        1. Introduction
          1. Source By Value
        2. Microbial
          1. By Value
        3. Mammalian
          1. By Value
        4. Others
          1. By Value
      2. By Manufacturing
        1. Introduction
          1. Manufacturing By Value
        2. In-house
          1. By Value
        3. Outsourced 
          1. By Value
      3. By Product
        1. Introduction
          1. Product By Value
        2. Monoclonal Antibodies 
          1. By Value
        3. Vaccines
          1. By Value
        4. Recombinant Proteins
          1. By Value
        5. Antisense & RNAi Therapeutics
          1. By Value
        6. Others
          1. By Value
      4. By Disease Category
        1. Introduction
          1. Disease Category By Value
        2. Oncology
          1. By Value
        3. Infectious Diseases
          1. By Value
        4. Immunological Disorders
          1. By Value
        5. Cardiovascular Disorders
          1. By Value
        6. Hematological Disorders
          1. By Value
        7. Others
          1. By Value
      5. By Type
        1. Introduction
          1. Type By Value
        2. Tumor Necrosis Factor (TNF) Inhibitor
          1. By Value
        3. T-cell Inhibitor
          1. By Value
        4. Selective Co-stimulation Modulators
          1. By Value
        5. Interleukin-6 (IL-6) or Interleukin-17 Blocker
          1. By Value
        6. Interleukin-1 (IL-1) Blocker
          1. By Value
        7. B-cell Inhibitor
          1. By Value
      6. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. Monoclonal Antibody
          1. By Value
        3. Recombinant Insulin
          1. By Value
        4. Vaccine
          1. By Value
        5. Blood Factor
          1. By Value
        6. Human Growth Hormone
          1. By Value
        7. Erythropoietin
          1. By Value
        8. Fusion Protein
          1. By Value
        9. Recombinant Enzyme
          1. By Value
        10. Interferon
          1. By Value
        11. Colony-stimulating Factor
          1. By Value
        12. Gene Therapy
          1. By Value
        13. Cell Therapy
          1. By Value
        14. Oligonucleotides
          1. By Value
        15. Peptide
          1. By Value
        16. Botulinum Toxin
          1. By Value
        17. Others
          1. By Value
      7. By Drug Type
        1. Introduction
          1. Drug Type By Value
        2. Branded Drugs
          1. By Value
        3. Generic Drugs
          1. By Value
      8. By Mode of Purchase
        1. Introduction
          1. Mode of Purchase By Value
        2. Prescription Drugs
          1. By Value
        3. Over-the-counter (OTC) Drugs
          1. By Value
      9. By Dosage Form
        1. Introduction
          1. Dosage Form By Value
        2. Injection
          1. By Value
        3. Tablets
          1. By Value
        4. Others
          1. By Value
      10. By Route of Administration
        1. Introduction
          1. Route of Administration By Value
        2. Parenteral
          1. By Value
        3. Oral
          1. By Value
        4. Others
          1. By Value
      11. By End-Users
        1. Introduction
          1. End-Users By Value
        2. Hospitals
          1. By Value
        3. Specialty Clinics
          1. By Value
        4. Homecare
          1. By Value
        5. Others
          1. By Value
      12. By Distribution Channel
        1. Introduction
          1. Distribution Channel By Value
        2. Hospital Pharmacy
          1. By Value
        3. Retail Pharmacy
          1. By Value
        4. Online Pharmacy
          1. By Value
        5. Others
          1. By Value
    15. Canada
    1. Introduction
    2. By Source
      1. Introduction
        1. Source By Value
      2. Microbial
        1. By Value
      3. Mammalian
        1. By Value
      4. Others
        1. By Value
    3. By Manufacturing
      1. Introduction
        1. Manufacturing By Value
      2. In-house
        1. By Value
      3. Outsourced 
        1. By Value
    4. By Product
      1. Introduction
        1. Product By Value
      2. Monoclonal Antibodies 
        1. By Value
      3. Vaccines
        1. By Value
      4. Recombinant Proteins
        1. By Value
      5. Antisense & RNAi Therapeutics
        1. By Value
      6. Others
        1. By Value
    5. By Disease Category
      1. Introduction
        1. Disease Category By Value
      2. Oncology
        1. By Value
      3. Infectious Diseases
        1. By Value
      4. Immunological Disorders
        1. By Value
      5. Cardiovascular Disorders
        1. By Value
      6. Hematological Disorders
        1. By Value
      7. Others
        1. By Value
    6. By Type
      1. Introduction
        1. Type By Value
      2. Tumor Necrosis Factor (TNF) Inhibitor
        1. By Value
      3. T-cell Inhibitor
        1. By Value
      4. Selective Co-stimulation Modulators
        1. By Value
      5. Interleukin-6 (IL-6) or Interleukin-17 Blocker
        1. By Value
      6. Interleukin-1 (IL-1) Blocker
        1. By Value
      7. B-cell Inhibitor
        1. By Value
    7. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Monoclonal Antibody
        1. By Value
      3. Recombinant Insulin
        1. By Value
      4. Vaccine
        1. By Value
      5. Blood Factor
        1. By Value
      6. Human Growth Hormone
        1. By Value
      7. Erythropoietin
        1. By Value
      8. Fusion Protein
        1. By Value
      9. Recombinant Enzyme
        1. By Value
      10. Interferon
        1. By Value
      11. Colony-stimulating Factor
        1. By Value
      12. Gene Therapy
        1. By Value
      13. Cell Therapy
        1. By Value
      14. Oligonucleotides
        1. By Value
      15. Peptide
        1. By Value
      16. Botulinum Toxin
        1. By Value
      17. Others
        1. By Value
    8. By Drug Type
      1. Introduction
        1. Drug Type By Value
      2. Branded Drugs
        1. By Value
      3. Generic Drugs
        1. By Value
    9. By Mode of Purchase
      1. Introduction
        1. Mode of Purchase By Value
      2. Prescription Drugs
        1. By Value
      3. Over-the-counter (OTC) Drugs
        1. By Value
    10. By Dosage Form
      1. Introduction
        1. Dosage Form By Value
      2. Injection
        1. By Value
      3. Tablets
        1. By Value
      4. Others
        1. By Value
    11. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Parenteral
        1. By Value
      3. Oral
        1. By Value
      4. Others
        1. By Value
    12. By End-Users
      1. Introduction
        1. End-Users By Value
      2. Hospitals
        1. By Value
      3. Specialty Clinics
        1. By Value
      4. Homecare
        1. By Value
      5. Others
        1. By Value
    13. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Hospital Pharmacy
        1. By Value
      3. Retail Pharmacy
        1. By Value
      4. Online Pharmacy
        1. By Value
      5. Others
        1. By Value
    14. U.K.
      1. By Source
        1. Introduction
          1. Source By Value
        2. Microbial
          1. By Value
        3. Mammalian
          1. By Value
        4. Others
          1. By Value
      2. By Manufacturing
        1. Introduction
          1. Manufacturing By Value
        2. In-house
          1. By Value
        3. Outsourced 
          1. By Value
      3. By Product
        1. Introduction
          1. Product By Value
        2. Monoclonal Antibodies 
          1. By Value
        3. Vaccines
          1. By Value
        4. Recombinant Proteins
          1. By Value
        5. Antisense & RNAi Therapeutics
          1. By Value
        6. Others
          1. By Value
      4. By Disease Category
        1. Introduction
          1. Disease Category By Value
        2. Oncology
          1. By Value
        3. Infectious Diseases
          1. By Value
        4. Immunological Disorders
          1. By Value
        5. Cardiovascular Disorders
          1. By Value
        6. Hematological Disorders
          1. By Value
        7. Others
          1. By Value
      5. By Type
        1. Introduction
          1. Type By Value
        2. Tumor Necrosis Factor (TNF) Inhibitor
          1. By Value
        3. T-cell Inhibitor
          1. By Value
        4. Selective Co-stimulation Modulators
          1. By Value
        5. Interleukin-6 (IL-6) or Interleukin-17 Blocker
          1. By Value
        6. Interleukin-1 (IL-1) Blocker
          1. By Value
        7. B-cell Inhibitor
          1. By Value
      6. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. Monoclonal Antibody
          1. By Value
        3. Recombinant Insulin
          1. By Value
        4. Vaccine
          1. By Value
        5. Blood Factor
          1. By Value
        6. Human Growth Hormone
          1. By Value
        7. Erythropoietin
          1. By Value
        8. Fusion Protein
          1. By Value
        9. Recombinant Enzyme
          1. By Value
        10. Interferon
          1. By Value
        11. Colony-stimulating Factor
          1. By Value
        12. Gene Therapy
          1. By Value
        13. Cell Therapy
          1. By Value
        14. Oligonucleotides
          1. By Value
        15. Peptide
          1. By Value
        16. Botulinum Toxin
          1. By Value
        17. Others
          1. By Value
      7. By Drug Type
        1. Introduction
          1. Drug Type By Value
        2. Branded Drugs
          1. By Value
        3. Generic Drugs
          1. By Value
      8. By Mode of Purchase
        1. Introduction
          1. Mode of Purchase By Value
        2. Prescription Drugs
          1. By Value
        3. Over-the-counter (OTC) Drugs
          1. By Value
      9. By Dosage Form
        1. Introduction
          1. Dosage Form By Value
        2. Injection
          1. By Value
        3. Tablets
          1. By Value
        4. Others
          1. By Value
      10. By Route of Administration
        1. Introduction
          1. Route of Administration By Value
        2. Parenteral
          1. By Value
        3. Oral
          1. By Value
        4. Others
          1. By Value
      11. By End-Users
        1. Introduction
          1. End-Users By Value
        2. Hospitals
          1. By Value
        3. Specialty Clinics
          1. By Value
        4. Homecare
          1. By Value
        5. Others
          1. By Value
      12. By Distribution Channel
        1. Introduction
          1. Distribution Channel By Value
        2. Hospital Pharmacy
          1. By Value
        3. Retail Pharmacy
          1. By Value
        4. Online Pharmacy
          1. By Value
        5. Others
          1. By Value
    15. Germany
    16. France
    17. Spain
    18. Italy
    19. Russia
    20. Nordic
    21. Benelux
    22. Rest of Europe
    1. Introduction
    2. By Source
      1. Introduction
        1. Source By Value
      2. Microbial
        1. By Value
      3. Mammalian
        1. By Value
      4. Others
        1. By Value
    3. By Manufacturing
      1. Introduction
        1. Manufacturing By Value
      2. In-house
        1. By Value
      3. Outsourced 
        1. By Value
    4. By Product
      1. Introduction
        1. Product By Value
      2. Monoclonal Antibodies 
        1. By Value
      3. Vaccines
        1. By Value
      4. Recombinant Proteins
        1. By Value
      5. Antisense & RNAi Therapeutics
        1. By Value
      6. Others
        1. By Value
    5. By Disease Category
      1. Introduction
        1. Disease Category By Value
      2. Oncology
        1. By Value
      3. Infectious Diseases
        1. By Value
      4. Immunological Disorders
        1. By Value
      5. Cardiovascular Disorders
        1. By Value
      6. Hematological Disorders
        1. By Value
      7. Others
        1. By Value
    6. By Type
      1. Introduction
        1. Type By Value
      2. Tumor Necrosis Factor (TNF) Inhibitor
        1. By Value
      3. T-cell Inhibitor
        1. By Value
      4. Selective Co-stimulation Modulators
        1. By Value
      5. Interleukin-6 (IL-6) or Interleukin-17 Blocker
        1. By Value
      6. Interleukin-1 (IL-1) Blocker
        1. By Value
      7. B-cell Inhibitor
        1. By Value
    7. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Monoclonal Antibody
        1. By Value
      3. Recombinant Insulin
        1. By Value
      4. Vaccine
        1. By Value
      5. Blood Factor
        1. By Value
      6. Human Growth Hormone
        1. By Value
      7. Erythropoietin
        1. By Value
      8. Fusion Protein
        1. By Value
      9. Recombinant Enzyme
        1. By Value
      10. Interferon
        1. By Value
      11. Colony-stimulating Factor
        1. By Value
      12. Gene Therapy
        1. By Value
      13. Cell Therapy
        1. By Value
      14. Oligonucleotides
        1. By Value
      15. Peptide
        1. By Value
      16. Botulinum Toxin
        1. By Value
      17. Others
        1. By Value
    8. By Drug Type
      1. Introduction
        1. Drug Type By Value
      2. Branded Drugs
        1. By Value
      3. Generic Drugs
        1. By Value
    9. By Mode of Purchase
      1. Introduction
        1. Mode of Purchase By Value
      2. Prescription Drugs
        1. By Value
      3. Over-the-counter (OTC) Drugs
        1. By Value
    10. By Dosage Form
      1. Introduction
        1. Dosage Form By Value
      2. Injection
        1. By Value
      3. Tablets
        1. By Value
      4. Others
        1. By Value
    11. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Parenteral
        1. By Value
      3. Oral
        1. By Value
      4. Others
        1. By Value
    12. By End-Users
      1. Introduction
        1. End-Users By Value
      2. Hospitals
        1. By Value
      3. Specialty Clinics
        1. By Value
      4. Homecare
        1. By Value
      5. Others
        1. By Value
    13. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Hospital Pharmacy
        1. By Value
      3. Retail Pharmacy
        1. By Value
      4. Online Pharmacy
        1. By Value
      5. Others
        1. By Value
    14. China
      1. By Source
        1. Introduction
          1. Source By Value
        2. Microbial
          1. By Value
        3. Mammalian
          1. By Value
        4. Others
          1. By Value
      2. By Manufacturing
        1. Introduction
          1. Manufacturing By Value
        2. In-house
          1. By Value
        3. Outsourced 
          1. By Value
      3. By Product
        1. Introduction
          1. Product By Value
        2. Monoclonal Antibodies 
          1. By Value
        3. Vaccines
          1. By Value
        4. Recombinant Proteins
          1. By Value
        5. Antisense & RNAi Therapeutics
          1. By Value
        6. Others
          1. By Value
      4. By Disease Category
        1. Introduction
          1. Disease Category By Value
        2. Oncology
          1. By Value
        3. Infectious Diseases
          1. By Value
        4. Immunological Disorders
          1. By Value
        5. Cardiovascular Disorders
          1. By Value
        6. Hematological Disorders
          1. By Value
        7. Others
          1. By Value
      5. By Type
        1. Introduction
          1. Type By Value
        2. Tumor Necrosis Factor (TNF) Inhibitor
          1. By Value
        3. T-cell Inhibitor
          1. By Value
        4. Selective Co-stimulation Modulators
          1. By Value
        5. Interleukin-6 (IL-6) or Interleukin-17 Blocker
          1. By Value
        6. Interleukin-1 (IL-1) Blocker
          1. By Value
        7. B-cell Inhibitor
          1. By Value
      6. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. Monoclonal Antibody
          1. By Value
        3. Recombinant Insulin
          1. By Value
        4. Vaccine
          1. By Value
        5. Blood Factor
          1. By Value
        6. Human Growth Hormone
          1. By Value
        7. Erythropoietin
          1. By Value
        8. Fusion Protein
          1. By Value
        9. Recombinant Enzyme
          1. By Value
        10. Interferon
          1. By Value
        11. Colony-stimulating Factor
          1. By Value
        12. Gene Therapy
          1. By Value
        13. Cell Therapy
          1. By Value
        14. Oligonucleotides
          1. By Value
        15. Peptide
          1. By Value
        16. Botulinum Toxin
          1. By Value
        17. Others
          1. By Value
      7. By Drug Type
        1. Introduction
          1. Drug Type By Value
        2. Branded Drugs
          1. By Value
        3. Generic Drugs
          1. By Value
      8. By Mode of Purchase
        1. Introduction
          1. Mode of Purchase By Value
        2. Prescription Drugs
          1. By Value
        3. Over-the-counter (OTC) Drugs
          1. By Value
      9. By Dosage Form
        1. Introduction
          1. Dosage Form By Value
        2. Injection
          1. By Value
        3. Tablets
          1. By Value
        4. Others
          1. By Value
      10. By Route of Administration
        1. Introduction
          1. Route of Administration By Value
        2. Parenteral
          1. By Value
        3. Oral
          1. By Value
        4. Others
          1. By Value
      11. By End-Users
        1. Introduction
          1. End-Users By Value
        2. Hospitals
          1. By Value
        3. Specialty Clinics
          1. By Value
        4. Homecare
          1. By Value
        5. Others
          1. By Value
      12. By Distribution Channel
        1. Introduction
          1. Distribution Channel By Value
        2. Hospital Pharmacy
          1. By Value
        3. Retail Pharmacy
          1. By Value
        4. Online Pharmacy
          1. By Value
        5. Others
          1. By Value
    15. Korea
    16. Japan
    17. India
    18. Australia
    19. Taiwan
    20. South East Asia
    21. Rest of Asia-Pacific
    1. Introduction
    2. By Source
      1. Introduction
        1. Source By Value
      2. Microbial
        1. By Value
      3. Mammalian
        1. By Value
      4. Others
        1. By Value
    3. By Manufacturing
      1. Introduction
        1. Manufacturing By Value
      2. In-house
        1. By Value
      3. Outsourced 
        1. By Value
    4. By Product
      1. Introduction
        1. Product By Value
      2. Monoclonal Antibodies 
        1. By Value
      3. Vaccines
        1. By Value
      4. Recombinant Proteins
        1. By Value
      5. Antisense & RNAi Therapeutics
        1. By Value
      6. Others
        1. By Value
    5. By Disease Category
      1. Introduction
        1. Disease Category By Value
      2. Oncology
        1. By Value
      3. Infectious Diseases
        1. By Value
      4. Immunological Disorders
        1. By Value
      5. Cardiovascular Disorders
        1. By Value
      6. Hematological Disorders
        1. By Value
      7. Others
        1. By Value
    6. By Type
      1. Introduction
        1. Type By Value
      2. Tumor Necrosis Factor (TNF) Inhibitor
        1. By Value
      3. T-cell Inhibitor
        1. By Value
      4. Selective Co-stimulation Modulators
        1. By Value
      5. Interleukin-6 (IL-6) or Interleukin-17 Blocker
        1. By Value
      6. Interleukin-1 (IL-1) Blocker
        1. By Value
      7. B-cell Inhibitor
        1. By Value
    7. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Monoclonal Antibody
        1. By Value
      3. Recombinant Insulin
        1. By Value
      4. Vaccine
        1. By Value
      5. Blood Factor
        1. By Value
      6. Human Growth Hormone
        1. By Value
      7. Erythropoietin
        1. By Value
      8. Fusion Protein
        1. By Value
      9. Recombinant Enzyme
        1. By Value
      10. Interferon
        1. By Value
      11. Colony-stimulating Factor
        1. By Value
      12. Gene Therapy
        1. By Value
      13. Cell Therapy
        1. By Value
      14. Oligonucleotides
        1. By Value
      15. Peptide
        1. By Value
      16. Botulinum Toxin
        1. By Value
      17. Others
        1. By Value
    8. By Drug Type
      1. Introduction
        1. Drug Type By Value
      2. Branded Drugs
        1. By Value
      3. Generic Drugs
        1. By Value
    9. By Mode of Purchase
      1. Introduction
        1. Mode of Purchase By Value
      2. Prescription Drugs
        1. By Value
      3. Over-the-counter (OTC) Drugs
        1. By Value
    10. By Dosage Form
      1. Introduction
        1. Dosage Form By Value
      2. Injection
        1. By Value
      3. Tablets
        1. By Value
      4. Others
        1. By Value
    11. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Parenteral
        1. By Value
      3. Oral
        1. By Value
      4. Others
        1. By Value
    12. By End-Users
      1. Introduction
        1. End-Users By Value
      2. Hospitals
        1. By Value
      3. Specialty Clinics
        1. By Value
      4. Homecare
        1. By Value
      5. Others
        1. By Value
    13. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Hospital Pharmacy
        1. By Value
      3. Retail Pharmacy
        1. By Value
      4. Online Pharmacy
        1. By Value
      5. Others
        1. By Value
    14. UAE
      1. By Source
        1. Introduction
          1. Source By Value
        2. Microbial
          1. By Value
        3. Mammalian
          1. By Value
        4. Others
          1. By Value
      2. By Manufacturing
        1. Introduction
          1. Manufacturing By Value
        2. In-house
          1. By Value
        3. Outsourced 
          1. By Value
      3. By Product
        1. Introduction
          1. Product By Value
        2. Monoclonal Antibodies 
          1. By Value
        3. Vaccines
          1. By Value
        4. Recombinant Proteins
          1. By Value
        5. Antisense & RNAi Therapeutics
          1. By Value
        6. Others
          1. By Value
      4. By Disease Category
        1. Introduction
          1. Disease Category By Value
        2. Oncology
          1. By Value
        3. Infectious Diseases
          1. By Value
        4. Immunological Disorders
          1. By Value
        5. Cardiovascular Disorders
          1. By Value
        6. Hematological Disorders
          1. By Value
        7. Others
          1. By Value
      5. By Type
        1. Introduction
          1. Type By Value
        2. Tumor Necrosis Factor (TNF) Inhibitor
          1. By Value
        3. T-cell Inhibitor
          1. By Value
        4. Selective Co-stimulation Modulators
          1. By Value
        5. Interleukin-6 (IL-6) or Interleukin-17 Blocker
          1. By Value
        6. Interleukin-1 (IL-1) Blocker
          1. By Value
        7. B-cell Inhibitor
          1. By Value
      6. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. Monoclonal Antibody
          1. By Value
        3. Recombinant Insulin
          1. By Value
        4. Vaccine
          1. By Value
        5. Blood Factor
          1. By Value
        6. Human Growth Hormone
          1. By Value
        7. Erythropoietin
          1. By Value
        8. Fusion Protein
          1. By Value
        9. Recombinant Enzyme
          1. By Value
        10. Interferon
          1. By Value
        11. Colony-stimulating Factor
          1. By Value
        12. Gene Therapy
          1. By Value
        13. Cell Therapy
          1. By Value
        14. Oligonucleotides
          1. By Value
        15. Peptide
          1. By Value
        16. Botulinum Toxin
          1. By Value
        17. Others
          1. By Value
      7. By Drug Type
        1. Introduction
          1. Drug Type By Value
        2. Branded Drugs
          1. By Value
        3. Generic Drugs
          1. By Value
      8. By Mode of Purchase
        1. Introduction
          1. Mode of Purchase By Value
        2. Prescription Drugs
          1. By Value
        3. Over-the-counter (OTC) Drugs
          1. By Value
      9. By Dosage Form
        1. Introduction
          1. Dosage Form By Value
        2. Injection
          1. By Value
        3. Tablets
          1. By Value
        4. Others
          1. By Value
      10. By Route of Administration
        1. Introduction
          1. Route of Administration By Value
        2. Parenteral
          1. By Value
        3. Oral
          1. By Value
        4. Others
          1. By Value
      11. By End-Users
        1. Introduction
          1. End-Users By Value
        2. Hospitals
          1. By Value
        3. Specialty Clinics
          1. By Value
        4. Homecare
          1. By Value
        5. Others
          1. By Value
      12. By Distribution Channel
        1. Introduction
          1. Distribution Channel By Value
        2. Hospital Pharmacy
          1. By Value
        3. Retail Pharmacy
          1. By Value
        4. Online Pharmacy
          1. By Value
        5. Others
          1. By Value
    15. Turkey
    16. Saudi Arabia
    17. South Africa
    18. Egypt
    19. Nigeria
    20. Rest of MEA
    1. Introduction
    2. By Source
      1. Introduction
        1. Source By Value
      2. Microbial
        1. By Value
      3. Mammalian
        1. By Value
      4. Others
        1. By Value
    3. By Manufacturing
      1. Introduction
        1. Manufacturing By Value
      2. In-house
        1. By Value
      3. Outsourced 
        1. By Value
    4. By Product
      1. Introduction
        1. Product By Value
      2. Monoclonal Antibodies 
        1. By Value
      3. Vaccines
        1. By Value
      4. Recombinant Proteins
        1. By Value
      5. Antisense & RNAi Therapeutics
        1. By Value
      6. Others
        1. By Value
    5. By Disease Category
      1. Introduction
        1. Disease Category By Value
      2. Oncology
        1. By Value
      3. Infectious Diseases
        1. By Value
      4. Immunological Disorders
        1. By Value
      5. Cardiovascular Disorders
        1. By Value
      6. Hematological Disorders
        1. By Value
      7. Others
        1. By Value
    6. By Type
      1. Introduction
        1. Type By Value
      2. Tumor Necrosis Factor (TNF) Inhibitor
        1. By Value
      3. T-cell Inhibitor
        1. By Value
      4. Selective Co-stimulation Modulators
        1. By Value
      5. Interleukin-6 (IL-6) or Interleukin-17 Blocker
        1. By Value
      6. Interleukin-1 (IL-1) Blocker
        1. By Value
      7. B-cell Inhibitor
        1. By Value
    7. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Monoclonal Antibody
        1. By Value
      3. Recombinant Insulin
        1. By Value
      4. Vaccine
        1. By Value
      5. Blood Factor
        1. By Value
      6. Human Growth Hormone
        1. By Value
      7. Erythropoietin
        1. By Value
      8. Fusion Protein
        1. By Value
      9. Recombinant Enzyme
        1. By Value
      10. Interferon
        1. By Value
      11. Colony-stimulating Factor
        1. By Value
      12. Gene Therapy
        1. By Value
      13. Cell Therapy
        1. By Value
      14. Oligonucleotides
        1. By Value
      15. Peptide
        1. By Value
      16. Botulinum Toxin
        1. By Value
      17. Others
        1. By Value
    8. By Drug Type
      1. Introduction
        1. Drug Type By Value
      2. Branded Drugs
        1. By Value
      3. Generic Drugs
        1. By Value
    9. By Mode of Purchase
      1. Introduction
        1. Mode of Purchase By Value
      2. Prescription Drugs
        1. By Value
      3. Over-the-counter (OTC) Drugs
        1. By Value
    10. By Dosage Form
      1. Introduction
        1. Dosage Form By Value
      2. Injection
        1. By Value
      3. Tablets
        1. By Value
      4. Others
        1. By Value
    11. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Parenteral
        1. By Value
      3. Oral
        1. By Value
      4. Others
        1. By Value
    12. By End-Users
      1. Introduction
        1. End-Users By Value
      2. Hospitals
        1. By Value
      3. Specialty Clinics
        1. By Value
      4. Homecare
        1. By Value
      5. Others
        1. By Value
    13. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Hospital Pharmacy
        1. By Value
      3. Retail Pharmacy
        1. By Value
      4. Online Pharmacy
        1. By Value
      5. Others
        1. By Value
    14. Brazil
      1. By Source
        1. Introduction
          1. Source By Value
        2. Microbial
          1. By Value
        3. Mammalian
          1. By Value
        4. Others
          1. By Value
      2. By Manufacturing
        1. Introduction
          1. Manufacturing By Value
        2. In-house
          1. By Value
        3. Outsourced 
          1. By Value
      3. By Product
        1. Introduction
          1. Product By Value
        2. Monoclonal Antibodies 
          1. By Value
        3. Vaccines
          1. By Value
        4. Recombinant Proteins
          1. By Value
        5. Antisense & RNAi Therapeutics
          1. By Value
        6. Others
          1. By Value
      4. By Disease Category
        1. Introduction
          1. Disease Category By Value
        2. Oncology
          1. By Value
        3. Infectious Diseases
          1. By Value
        4. Immunological Disorders
          1. By Value
        5. Cardiovascular Disorders
          1. By Value
        6. Hematological Disorders
          1. By Value
        7. Others
          1. By Value
      5. By Type
        1. Introduction
          1. Type By Value
        2. Tumor Necrosis Factor (TNF) Inhibitor
          1. By Value
        3. T-cell Inhibitor
          1. By Value
        4. Selective Co-stimulation Modulators
          1. By Value
        5. Interleukin-6 (IL-6) or Interleukin-17 Blocker
          1. By Value
        6. Interleukin-1 (IL-1) Blocker
          1. By Value
        7. B-cell Inhibitor
          1. By Value
      6. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. Monoclonal Antibody
          1. By Value
        3. Recombinant Insulin
          1. By Value
        4. Vaccine
          1. By Value
        5. Blood Factor
          1. By Value
        6. Human Growth Hormone
          1. By Value
        7. Erythropoietin
          1. By Value
        8. Fusion Protein
          1. By Value
        9. Recombinant Enzyme
          1. By Value
        10. Interferon
          1. By Value
        11. Colony-stimulating Factor
          1. By Value
        12. Gene Therapy
          1. By Value
        13. Cell Therapy
          1. By Value
        14. Oligonucleotides
          1. By Value
        15. Peptide
          1. By Value
        16. Botulinum Toxin
          1. By Value
        17. Others
          1. By Value
      7. By Drug Type
        1. Introduction
          1. Drug Type By Value
        2. Branded Drugs
          1. By Value
        3. Generic Drugs
          1. By Value
      8. By Mode of Purchase
        1. Introduction
          1. Mode of Purchase By Value
        2. Prescription Drugs
          1. By Value
        3. Over-the-counter (OTC) Drugs
          1. By Value
      9. By Dosage Form
        1. Introduction
          1. Dosage Form By Value
        2. Injection
          1. By Value
        3. Tablets
          1. By Value
        4. Others
          1. By Value
      10. By Route of Administration
        1. Introduction
          1. Route of Administration By Value
        2. Parenteral
          1. By Value
        3. Oral
          1. By Value
        4. Others
          1. By Value
      11. By End-Users
        1. Introduction
          1. End-Users By Value
        2. Hospitals
          1. By Value
        3. Specialty Clinics
          1. By Value
        4. Homecare
          1. By Value
        5. Others
          1. By Value
      12. By Distribution Channel
        1. Introduction
          1. Distribution Channel By Value
        2. Hospital Pharmacy
          1. By Value
        3. Retail Pharmacy
          1. By Value
        4. Online Pharmacy
          1. By Value
        5. Others
          1. By Value
    15. Mexico
    16. Argentina
    17. Chile
    18. Colombia
    19. Rest of LATAM
    1. Biologics Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Bristol-Myers Squibb Company
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Merck KGaA
    3. Novartis AG
    4. Novo Nordisk A/S
    5. Pfizer Inc
    6. Johnson & Johnson Services Inc
    7. Hoffmann La Roche Ltd
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Available for purchase with detailed segment data, forecasts, and regional insights.

Get This Report

Download Free Sample

Note: Please ensure you provide an active email address as we will be sending sample details via email.
The button will be active once the above form is filled

Our Clients:

LG Electronics
AMCAD Engineering
KOBE STEEL LTD.
Hindustan National Glass & Industries Limited
Voith Group
International Paper
Hansol Paper
Whirlpool Corporation
Sony
Samsung Electronics
Qualcomm
Google
Fiserv
Veto-Pharma
Nippon Becton Dickinson
Merck
Argon Medical Devices
Abbott
Ajinomoto
Denon
Doosan
Meiji Seika Kaisha Ltd
LG Chemicals
LCY chemical group
Bayer
Airrane
BASF
Toyota Industries
Nissan Motors
Neenah
Mitsubishi
Hyundai Motor Company

We are featured on :

Address:
Office 515 A, Amanora Chambers,
Amanora Park Town, Hadapsar,
Pune 411028, Maharashtra, India.
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
DMCA.com Protection Status
Secure Payments:
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.